Basilea Pharmaceutica AG (BPMUF)

Basilea Pharmaceutica AG Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	722	553	502	590	532	649
Market Cap Growth	38.06%	10.13%	-14.92%	11.03%	-18.08%	24.93%
Enterprise Value	683	608	600	688	605	749
Last Close Price	67.75	52.83	41.00	52.00	41.00	60.34
PE Ratio	7.91	6.46	40.47	44.94	-	-
PS Ratio	2.43	2.40	2.68	3.69	3.27	4.50
PB Ratio	5.57	6.19	-42.28	-26.35	-8.27	-5.63
P/TBV Ratio	5.59	6.22	-	-	-	-
P/FCF Ratio	7.37	6.90	31.48	139.32	-	-
P/OCF Ratio	7.23	6.74	29.69	77.36	-	-
EV/Sales Ratio	2.30	2.64	3.20	4.31	3.72	5.19
EV/EBITDA Ratio	6.79	8.72	21.78	29.31	154.82	-
EV/EBIT Ratio	7.11	8.93	23.05	30.58	183.33	-
EV/FCF Ratio	6.97	7.58	37.59	162.43	-	-
Debt / Equity Ratio	0.94	1.38	-12.86	-9.03	-3.74	-2.37
Debt / EBITDA Ratio	1.21	1.71	5.05	7.76	41.61	-
Debt / FCF Ratio	1.24	1.54	9.57	47.76	-	-
Asset Turnover	1.08	0.97	0.80	0.63	0.62	0.57
Inventory Turnover	4.69	3.99	4.13	4.18	5.33	6.11
Quick Ratio	5.40	3.93	2.48	1.96	1.22	3.87
Current Ratio	6.32	4.85	3.20	2.34	1.38	4.46
Return on Equity (ROE)	121.15%	218.58%	-	-	-	-
Return on Assets (ROA)	21.88%	17.89%	6.95%	5.56%	0.79%	-5.93%
Return on Capital (ROIC)	29.07%	24.78%	9.61%	7.96%	1.25%	-10.88%
Return on Capital Employed (ROCE)	35.70%	29.10%	17.40%	14.30%	4.10%	-
Earnings Yield	12.65%	15.48%	2.47%	2.23%	-1.41%	-2.56%
FCF Yield	13.57%	14.50%	3.18%	0.72%	-6.73%	-9.74%
Buyback Yield / Dilution	-15.14%	-14.10%	-1.67%	-2.24%	-13.62%	4.41%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.